Mandal Pravat K, Pettegrew Jay W
Laboratory of Neurophysics, Department of Psychiatry, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania 15261, USA.
Neurochem Res. 2004 Feb;29(2):447-53. doi: 10.1023/b:nere.0000013750.80925.25.
Amyloid peptide (Abeta) is the major protein constituent of neuritic plaques in Alzheimer's disease (AD). This peptide is an amphipathic molecule that perturbs membranes and binds to raft-like membranes composed of gangliosides. Ganglioside GM1 binds tightly with Abeta and it is speculated that GM1 inhibits Abeta from undergoing alpha-helix to beta-sheet conformational changes. Although the role of gangliosides in conformational changes of Abeta have been studied, the specific nature of these interactions have not been reported. In the present report multidimensional NMR studies of ganglioside-Abeta interactions were conducted in sodium dodecyl sulphate (SDS) micelles, a membrane-mimicking environment. These studies reveal that asialoGM1 binds specifically with Abeta in a manner which could prevent beta-sheet formation. but that ganglioside GT1b does not bind Abeta. Plausible pathways for the involvement of gangliosides in amyloidogenesis are discussed.
淀粉样肽(Aβ)是阿尔茨海默病(AD)中神经炎性斑块的主要蛋白质成分。这种肽是一种两亲性分子,会干扰细胞膜并与由神经节苷脂组成的筏样膜结合。神经节苷脂GM1与Aβ紧密结合,据推测GM1可抑制Aβ从α螺旋向β折叠构象转变。尽管已经研究了神经节苷脂在Aβ构象变化中的作用,但这些相互作用的具体性质尚未见报道。在本报告中,在模拟膜环境的十二烷基硫酸钠(SDS)胶束中对神经节苷脂 - Aβ相互作用进行了多维核磁共振研究。这些研究表明,脱唾液酸GM1以一种可以防止β折叠形成的方式与Aβ特异性结合,但神经节苷脂GT1b不与Aβ结合。文中讨论了神经节苷脂参与淀粉样蛋白生成的可能途径。